New Malaria Vaccine Proven Effective in Phase 3 Study New Malaria Vaccine Proven Effective in Phase 3 Study
The vaccine protected children under the age of 1.5 years against infection with an efficacy of 68%-75%.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
More News: Allergy | Allergy & Immunology | Children | Infectious Diseases | Malaria | Malaria Vaccine | Study | Vaccines